Login / Signup
Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials.
M Tarazi
R G Gaffney
R Feng
V P Werth
Published in:
The British journal of dermatology (2019)
Keyphrases
</>
disease activity
clinical trial
systemic lupus erythematosus
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
phase ii
open label
double blind
phase iii